Carrier advocacy coverage letter for uterine fibroid embolization (UFE) and uterine artery embolization (UAE) for the treatment of uterine fibroids and adenomyosis

The Uterine Fibroid Embolization and Uterine Artery embolization evidence-based letter was written by IR physicians that are members of SIR's Carrier Advocacy Workgroup. The letter is intended to help IRs during the authorization, appeal and denial process with any payor denying this service.

Policy coverage topic: Uterine Fibroid Embolization and Uterine Artery Embolization for the treatment of Uterine Fibroids and Adenomyosis.

A subscription model applies to this product. The text, graphics and information are of a general nature; it is not a substitute for obtaining medical advice. We may update the documents at any time without prior notice.